Impact of Concurrent Foot Pain on Health and Functional Status in People with Knee Osteoarthritis: Data From the Osteoarthritis Initiative
Kade L Paterson, Rana S Hinman, David J Hunter, Tim V Wrigley, Kim L Bennell
Arthritis Care & Research | WILEY-BLACKWELL | Published : 2015
Awarded by NIH, a branch of the Department of Health and Human Services
Awarded by Australian Research Council
This article was prepared using an Osteoarthritis Initiative public-use data set and does not necessarily reflect the opinions or views of the Osteoarthritis Initiative investigators, the NIH, or the private funding partners. The authors of this article are not part of the Osteoarthritis Initiative investigative team. The Osteoarthritis Initiative is a public-private partnership composed of 5 contracts (N01-AR-2-2258, N01-AR-2-2259, N01-AR-2-2260, N01-AR-2-2261, and N01-AR-2-2262) funded by the NIH, a branch of the Department of Health and Human Services, and conducted by the Osteoarthritis Initiative Investigators. Private funding partners include Merck Research Laboratories, Novartis Pharmaceuticals Corporation, GlaxoSmithKline, and Pfizer. Private sector funding for the Osteoarthritis Initiative is managed by the Foundation for the NIH. Drs. Hinman and Bennell's work was partially supported by Australian Research Council Future Fellowships (FT130100175 and FT0991413).Dr. Hinman has received royalties from the sales of an educational osteoarthritis DVD and the Gel Melbourne OA shoe (Asics). Dr. Hunter has received royalties from the sale of a patellofemoral brace (DJO). Dr. Bennell has received consultant fees (less than0,000) from Physitrack and has received royalties from the sales of an educational osteoarthritis DVD and the Gel Melbourne OA shoe (Asics).